Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0U3KX
|
|||
Drug Name |
PMID29473428-Compound-70
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
FLEXUS BIOSCIENCES, INC
|
|||
Structure |
Download2D MOL |
|||
Formula |
C23H23ClFN3O2
|
|||
Canonical SMILES |
CC(C(=O)NC1=CC=C(C=C1)Cl)N2CCC(CC2)OC3=C4C=C(C=CC4=NC=C3)F
|
|||
InChI |
1S/C23H23ClFN3O2/c1-15(23(29)27-18-5-2-16(24)3-6-18)28-12-9-19(10-13-28)30-22-8-11-26-21-7-4-17(25)14-20(21)22/h2-8,11,14-15,19H,9-10,12-13H2,1H3,(H,27,29)
|
|||
InChIKey |
JOMPEBQANPZAPO-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Indoleamine 2,3-dioxygenase 1 (IDO1) | Target Info | Inhibitor | [1] |
Target's Patent Info | Indoleamine 2,3-dioxygenase 1 (IDO1) | Target's Patent Info | [1] | |
BioCyc | Superpathway of tryptophan utilization | |||
Tryptophan degradation | ||||
L-kynurenine degradation | ||||
Tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde | ||||
NAD de novo biosynthesis | ||||
KEGG Pathway | Tryptophan metabolism | |||
Metabolic pathways | ||||
African trypanosomiasis | ||||
NetPath Pathway | TSLP Signaling Pathway | |||
IL5 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | ||||
Pathwhiz Pathway | Tryptophan Metabolism | |||
Reactome | Tryptophan catabolism | |||
WikiPathways | Tryptophan metabolism | |||
Metabolism of amino acids and derivatives |
References | Top | |||
---|---|---|---|---|
REF 1 | A patent review of IDO1 inhibitors for cancer.Expert Opin Ther Pat. 2018 Apr;28(4):317-330. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.